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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
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Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
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Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
GDP  Gross Domestic Product 
GP General Practitioners 
NICU   Neonatal-intensive care unit 
PPP   Purchasing Power Parity 
ROP Retinopathy of Prematurity 
VA Visual Acuity 
WHO  World Health Organisation  
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3 Population and Healthcare Overview 
The population of Poland is 37,975,841 (World Bank, 2018a) and birth rate is estimated at 
10.1 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Poland has a reported population density of 124 people per square kilometre in 2017 and 
this has risen from 98 people per square kilometre in 1961 (World Bank, 2018c). In terms of 
healthcare facilities, the total density of hospitals in 2013 was 0.94 per 100,000 population 
(WHO, 2016a). Infant mortality in 2017 is estimated at 4 deaths/1,000 live births in total 
(World Bank, 2018d). 
The average life expectancy in Poland is estimated at 77.5 years (World Bank, 2018e), with 
a death rate of 10.2 deaths/1,000 population in 2016 (World Bank, 2018f). Poland has a gross 
national income per capita (PPP int. $, 2013) of $22,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $1,570 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 6.3% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Poland between 1960 and 2017 
 
Source: Information sourced from World Bank (2018)
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4 Vision Screening Commissioning and Guidance 
Vision screening is organised nationally in Poland, there are no regional differences. The vision 
screening programme is not embedded into a general preventative child healthcare screening system. 
The content of the vision screening programme is decided upon by the Ministry of Health, and 
implemented nationally. TŚĞ ƉƌŽŐƌĂŵŵĞ ƐƚĂƌƚĞĚ ŝŶ  ? ? ? ? ?Ɛ and has not been changed since its 
implementation.  
Vision screening is conducted by General Practitioners (GP), ophthalmologists, paediatricians and 
nurses, of which there are approximately 850 per million population. No other general health 
professionals have been identified who could screen with additional training. There is no specific 
training to perform vision screening. Vision screening is performed during vaccination visits. 
Invitations are sent by the local GPs office; there is no central database. 
There are national general health screening guidelines for vision screening and the programme is 
reviewed once every several years. Any revisions would be implemented by the Ministry of Health and 
funded by state health insurance. Any revisions to the vision screening programme are conducted 
through consultations between the Ministry of Health and ophthalmology consultants.  
There are no methods for quality monitoring imposed by the government. There has been no research 
concerning the vision screening programme carried out in Poland. There has also been no cost-
effectiveness or any other studies into the effectiveness of the vision screening programme.  
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5 Screening programme  
The target conditions screened for are retinopathy of prematurity (ROP), congenital eye disorders, 
reduced visual acuity and strabismus. The health care professionals delivering vision screening, venue 
for screening and tests used vary depending on the age of the child as shown in Tables 1, 2 and 3 
respectively. Specific details of the screening offered within each age group are described more fully 
in sections 5.1 to 5.4 below  
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist in outpatient clinics or 
within hospitals using eye inspection and retinal examinations. This occurs four weeks after birth; 
follow-ups are conducted at 2 to 4 week intervals depending on a diagnosis of ROP.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by either a paediatrician or a GP. This is 
conducted at either 1 or 3 months of age, in a child healthcare centre using a fundus red reflex 
examination, fixation and pupillary reflexes. Referral is made if any suspected abnormality is 
identified, babies are referred for further diagnostic examination after one abnormal or one 
inconclusive test result.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by either a paediatrician or a GP. This is conducted in the 
GPs office by both professionals. At the age of 1 to 3 months, fixation is conducted and at the age of 
36 months, the Hirschberg test is conducted. Referral is made if any suspected abnormality is 
identified, children are referred for further diagnostic examination after one abnormal or inconclusive 
test result.  
5.4 Vision screening - 36 months to 7 years 
Children aged 3 to 7 years are screened by a paediatrician, GP or nurse. This is conducted in a GPs 
office, where visual acuity (VA) and Hirschberg test are conducted. Colour vision is assessed after the 
age of 7 years. VA and Hirschberg test are assessed at 3, 4, 5, 6 and 7 years of age.  
 
At the age of 3 years, the GP or paediatrician will conduct the VA assessment, at the age of 7 years, 
the nurse, GP, or paediatrician will conduct the screening. The optotype charts used for VA 
measurement are numbers or pictures.   These are crowded linear tests or uncrowded single 
optotypes for pre-schoolers. From the age of 7 years the Snellen chart is used.   
 
At the age of 3 years, one line of VA difference, or strabismus are referral criteria for further diagnostic 
examination by an ophthalmologist. Children are referred after one abnormal or inconclusive test 
result.  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 
Paediatrician Nurse Ophthalmologist GP 
Preterm babies  
 
× 
 
× 
 
9 
 
× 
0 to 3 months  
 
9 
 
× 
 
× 
 
9 
3 to 36 months  
 
9 
 
× 
 
× 
 
9 
3 to 7 years  
 
9 
 
9 
 
× 
 
9 
 
 
  
Version 2. 
Summary Vision Screening Data: Poland                                                                                                    
 
6 
 
Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye inspection Red reflex  Fixation Pupillary 
reflexes 
Retinal 
examination 
Hirschberg  Visual acuity Colour vision 
Preterm 
babies  
 
9 
 
× 
 
× 
 
× 
 
9 
 
× 
 
× 
 
× 
0 to 3 
months  
 
× 
 
9 
 
9 
 
9 
 
× 
 
× 
 
× 
 
× 
3 to 36 
months  
 
× 
 
× 
 
9 
 
× 
 
× 
 
9 
 
× 
 
× 
3 to 7 years  
 
× 
 
× 
 
× 
 
× 
 
× 
 
9 
 
9 
 
9 
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Table 3: Location of vision screening for each age group  
Table 3 
Child Health Care 
Centre 
Hospital Outpatient Clinic GP office Paediatrician office 
Preterm babies  
 
× 
 
9 
 
9 
 
× 
 
× 
0 to 3 months  
 
9 
 
× 
 
× 
 
× 
 
× 
3 to 36 months  
 
× 
 
× 
 
× 
 
9 
 
× 
3 to 7 years  
 
× 
 
× 
 
× 
 
9 
 
× 
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6 Automated Screening 
Automated vision screening is carried out using handheld, portable devices designed to detect 
presence of refractive error in infants and young children. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for amblyopia 
which focus on detection of the actual condition and the resulting visual loss.  
In Poland, automated screening is not part of standard vision screening and therefore is not regularly 
conducted. However, if it is conducted, the Retinomax autorefractor is used. This device costs 
approximately 36,000PLN (8,420 Euros), the maintenance costs and the replacement date is unknown. 
It is not mandatory for a paediatrician to have this equipment and they are not required to pay for it. 
If autrorefraaction is carried out, it is conducted in conjunction with a VA assessment. There is no 
comparative data between areas that use autorefraction and areas that do not. These devices are only 
used on children aged 7-14 years and there are no specified risk factors for referral. If a child passes 
the VA test, but fails the autorefraction, they are not referred. This test would be used in collaboration 
with a VA assessment. There is no comparative data between areas that do and do not conduct 
automated screening.  
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7 Provision for Visually Impaired  
There are 14 schools in Poland for blind or severely visually impaired children. These are mainly 
located in cities like Warsaw, Cracow, Bydgoszcz, Chorzow, Dabrowa Gornicza. It is estimated that 
more than 500,000 people have severe visual impairment in Poland, with the number of school 
attenders at about 4,745. The costs, per child, of these schools is not known. Visually impaired children 
who attend mainstream primary school are offered support such as magnifying glasses, and 30% of 
any costs are covered by the National Health Administration; the rest is paid for by parents.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia in Poland, by the age of 7 years, is estimated as 3%, 
with prevalence of persistent amblyopia (missed by screening or failed treatment) estimated as 1% by 
the age of 7 years. The prevalence of strabismus, by the age of 7 years, is estimated as 5%. From all 
cases of amblyopia it is estimated that the distribution of strabismic amblyopia is 30%, refractive 
amblyopia 40%, combined mechanism amblyopia 20% and deprivation amblyopia 10%. 
8.2 Coverage 
It is approximated that 99% of children are invited for vision screening; invitations are sent out in the 
form of a letter with a vaccination invitation by the GP. Approximately 0.5% of children in Poland do 
not attend obligatory vaccination visits (according to the report of The Supreme Chamber of Control, 
2017), data from 29.5% of attenders do not contain visual acuity measurements. The attendance of 
vision screening before the age of 7 years is estimated as 70%. The percentage of compliance with 
referral after an abnormal screening test result is estimated at 95%.  
8.3 Screening evaluation 
Estimations concerning the screening evaluation in Poland are based on the percentage of prescribed 
treatment from referred children in the Podlasie region. The percentage of false negatives for vision 
screening, after the screening has been completed is estimated as 2%. The percentage of false 
positives for vision screening is low and estimated by the country representative as 0.5%. The positive 
predictive value of a refer results after vision screening is estimated as 98%. The sensitivity and 
specificity of vision screening is not known.  
8.4 Treatment success 
The percentage of infants treated for congenital eye disorders is estimated as 0.1%. The percentage 
of children treated for strabismus after being screened before the age of 7 years is estimated as 4%. 
The percentage of all children treated for strabismus before the age of 7 years is estimated as 3.5%. 
The percentage of children treated for amblyopia, after being screened before the age of 7 years is 
estimated as 2%.  
The number of patients treated by ophthalmologists for congenital cataracts is estimated as 90 per 
year, the number of patients treated by ophthalmologists for amblyopia is estimated as 7,500 per year 
and the number of patients treated for strabismus by ophthalmologists and orthoptists is estimated 
as 1,316 per year. All eligible children are offered treatment. Ophthalmologists are the only 
professional to prescribe glasses for children under the age of 7 years. Other treatments include 
patching and cataract surgery as appropriate. 
No information has been provided on sample sizes and no relevant sources have been provided 
concerning the percentages reported in this section. 
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs, per year, for vision screening professionals in Poland has not been reported. The 
salary costs per hour for vision screening professionals is estimated at 19 PLN (4.5 Euros, 20/12/2018). 
The costs to train general preventative child healthcare screening professionals, from leaving 
secondary education to qualification has not been reported. The screening costs per year for vision 
screening and the screening costs per child for vision screening are not known.  
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients with refractive amblyopia and/or strabismic 
amblyopia are not known.  
9.3 Cost of Treatment for strabismus  
The estimated costs for strabismus surgery, including follow-up, are 2,515 PLN (587 Euros, 
20/12/2018) per patient. Each patient requires 2 visits.  
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery, including follow-up of deprivation amblyopia, are 
approximately 2,980 PLN (695 Euros, 20/12/2018) per patient. 
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